NEW YORK--(BUSINESS WIRE)--The Law Offices of Vincent Wong are investigating the Board of Directors of Orthovita, Inc. (Nasdaq: VITA) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Stryker Corporation (NYSE: SYK). Under the terms of the proposed deal, Orthovita shareholders will receive $3.85 per share in cash for a total transaction value of approximately $316 million.
The investigation concerns whether the Orthovita Board of Directors breached their fiduciary duties to Orthovita stockholders by failing to adequately shop the Company before entering into this transaction and whether Stryker Corporation is underpaying for Orthovita shares. According to Thomson/First Call, at least one analyst set a price target for Orthovita stock at $4.00 per share.
If you own common stock in Orthovita and wish to obtain additional information, please contact Vincent Wong, Esq. either via email vw@wongesq.com, by telephone at 212.584.2740, or visit http://www.wongesq.com/orthovita-inc.html.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.